Investing Ideas
/
French Pharmaceuticals & Biotech High Insider Buying

French Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Novacyt

Market Cap: €27.1m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

ALNOV

€0.37

-0.1%

-23.5%